Hariprasad Gali to Radiopharmaceuticals
This is a "connection" page, showing publications Hariprasad Gali has written about Radiopharmaceuticals.
Connection Strength
2.194
-
Synthesis and in vivo evaluation of gallium-68-labeled glycine and hippurate conjugates for positron emission tomography renography. J Labelled Comp Radiopharm. 2015 Jan; 58(1):14-9.
Score: 0.450
-
Single-step radiosynthesis and in vivo evaluation of a novel fluorine-18 labeled hippurate for use as a PET renal agent. Nucl Med Biol. 2012 Nov; 39(8):1195-201.
Score: 0.381
-
Synthesis and in vivo evaluation of p-18F-Fluorohippurate as a new radiopharmaceutical for assessment of renal function by PET. J Nucl Med. 2011 Jan; 52(1):147-53.
Score: 0.340
-
Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting avß3 integrin expression. Bioorg Med Chem Lett. 2010 Oct 15; 20(20):5969-72.
Score: 0.332
-
Chemical synthesis of Escherichia coli ST(h) analogues by regioselective disulfide bond formation: biological evaluation of an (111)In-DOTA-Phe(19)-ST(h) analogue for specific targeting of human colon cancers. Bioconjug Chem. 2002 Mar-Apr; 13(2):224-31.
Score: 0.185
-
Production of [13N]ammonia from [13C]methanol on a 7.5?MeV cyclotron using 13C(p, n)13N reaction: Detection of myocardial infarction in a mouse model. Appl Radiat Isot. 2019 Aug; 150:19-24.
Score: 0.152
-
Primary radiation dosimetry of a novel PET radiopharmaceutical 68Ga-NODAGA-glycine in comparison with 99mTc-DTPA in renal studies. Hell J Nucl Med. 2017 Sep-Dec; 20(3):241-246.
Score: 0.138
-
A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG. Appl Radiat Isot. 2014 Jul; 89:167-75.
Score: 0.106
-
Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J Nucl Med. 2003 May; 44(5):823-31.
Score: 0.050
-
Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties. Bioconjug Chem. 2003 Jan-Feb; 14(1):93-102.
Score: 0.049
-
Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nucl Med Biol. 2003 Feb; 30(2):101-9.
Score: 0.012